The medical diagnostics landscape is witnessing a groundbreaking shift with GE HealthCare's innovative integration of artificial intelligence into imaging technology. Recently, the U.S. Food and Drug Administration granted 510(k) clearance to GE HealthCare's Aurora nuclear medicine system and
Theranostic nuclear medicine presents a compelling opportunity to diagnose and treat cancer using radioactive isotopes capable of emitting imaging and therapeutic particles. One such promising isotope is Terbium-161 (Tb-161), which emits both beta particles and low-energy photons, making it
A groundbreaking development in the realm of medical imaging is offering refreshing insights into the lingering effects of COVID-19, known as long COVID, which continues to affect countless individuals even after initial recovery. The new approach utilizes a specialized PET imaging method designed
The nuclear medicine and radiopharmaceuticals market is on a trajectory to remarkable growth, with projections reaching USD 11.05 billion by 2030. Such significant expansion underscores the transformative impact of advancements in healthcare and diagnostic technologies, particularly in the realms
In a cutting-edge study recently published, researchers have uncovered critical insights into dopamine's role in cognitive flexibility, a core component of executive function necessary for adapting behavior to new and changing environments. Utilizing positron emission tomography (PET) imaging, the
The nuclear medicine market stands on the cusp of significant growth, poised for remarkable expansion as medical technology continues to advance and the demand for precise diagnostic and therapeutic practices increases. By 2035, researchers expect a substantial surge in this market, driven by a
